NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer

Medical Oncology

Volumn 31, Issue 8, 2014, Pages

  Yuan, Dawei ^a   Zhu, Kun ^a   Dang, Chengxue ^a   Zheng, Yuewen ^b   Yan, Rong ^a   Shi, Lei ^a   Li, Kang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gastric cancer; NS5ATP9; Peripheral blood mononuclear cells; Prognosis; Receiver operating characteristic curve; Survival

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; NS5ATP9 PROTEIN; OXALIPLATIN; PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; KIAA0101 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL LEVEL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; TUMOR RECURRENCE;

AGED; CARCINOEMBRYONIC ANTIGEN; CARRIER PROTEINS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906101599     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0106-5     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. vol Ed. 4. World Health Organization; 2010.
3. Pietrantonio F, De Braud F, Da Prat V, Perrone F, Pierotti MA, Gariboldi M, et al. A Review on Biomarkers for Prediction of Treatment Outcome in Gastric Cancer. Anticancer Res. 2013;33(4):1257-66.
4. Simpson F, Lammerts van Bueren K, Butterfield N, Bennetts JS, Bowles J, Adolphe C, et al. The PCNA-associated factor KIAA0101/p15PAF binds the potential tumor suppressor product p33ING1b. Exp Cell Res. 2006;312(1):73-85. (Pubitemid 41668593)
5. Yu P, Huang B, Shen M, Lau C, Chan E, Michel J, et al. p15 (PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene. 2001;20(4):484.
6. Petroziello J, Yamane A, Westendorf L, Thompson M, McDonagh C, Cerveny C, et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene. 2004;23(46):7734-45. (Pubitemid 39424932)
7. Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, Yoshida A, et al. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer. 2005;103(9):1785-90. (Pubitemid 40563249)
8. Yuan RH, Jeng YM, Pan HW, Hu FC, Lai PL, Lee PH, et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2007;13(18):5368-76.
9. Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, et al. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res. 2011;9(8):1091-9.
10. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer. 2012;75(1):110-8.
11. Jain M, Zhang L, Patterson EE, Kebebew E. KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS ONE. 2011;6(11):e26866.
12. Hosokawa M, Takehara A, Matsuda K, Eguchi H, Ohigashi H, Ishikawa O, et al. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res. 2007;67(6):2568-76. (Pubitemid 46548942)
13. Zhu K, Diao D, Dang C, Shi L, Wang J, Yan R et al. Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer. Cancer Science. 2013.
14. Liew C-C, Ma J, Tang H-C, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006;147(3):126-32. (Pubitemid 43288168)
15. Manoel-Caetano FS, Xavier DJ, Evangelista AF, Takahashi P, Collares CV, Puthier D et al. Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease. Gene. 2012.
16. Sun C-J, Zhang L, Zhang W-Y. Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers. J Perinat Med. 2009;37(6):609-16.
17. Edwards CJ, Feldman JL, Beech J, Shields KM, Stover JA, Trepicchio WL, et al. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med. 2007;13(1-2):40.
18. Bluth M, Lin Y-y, Zhang H, Viterbo D, Zenilman M. Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis. Archives of Surgery. 2008;143(3):227.
19. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci. 2003;100(4):1896-901. (Pubitemid 36254545)
20. Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res. 2003;63(18):6069-75. (Pubitemid 37187512)
21. Edge SB BD, Compton CC, Fritz AG, Greene FL, Trotti A, editors, editor. AJCC cancer staging manual (7th ed). New York: NY: Springer; 2010.
22. Prelich G, Tan C-K, Kostura M, Mathews MB, So AG, Downey KM, et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-d auxiliary protein. Nature. 1987;326(6112):517-20. (Pubitemid 17055499)
23. ZhangZ,ShibaharaK-i,StillmanB. PCNAconnectsDNAreplication to epigenetic inheritance in yeast. Nature. 2000;408(6809):221-5.
24. Cheung K-J, Mitchell D, Lin P, Li G. The tumor suppressor candidate p33ING1 mediates repair of UV-damaged DNA. Cancer Res. 2001;61(13):4974-7. (Pubitemid 32681521)
25. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 1994;371(6497):534-7. (Pubitemid 24306614)
26. Chang C-N, Feng M-J, Chen Y-L, Yuan R-H, Jeng Y-M. p15PAF Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression. PLoS ONE. 2013;8(4):e61196.
27. Williams MA, Newland AC, Kelsey SM. Potential for Monocyte-Mediated Immunotherapy ring Infection and Malignancy. Part I: Apoptosis Induction and Cytotoxic Mechanisms. Leukemia & lymphoma. 1999;34(1-2):1-23. (Pubitemid 29248655)
28. Sakai Y, Honda M, Fujinaga H, Tatsumi I, Mizukoshi E, Nakamoto Y, et al. Common transcriptional signature of tumorinfiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients. Cancer Res. 2008;68(24):10267-79.
29. Kitkumthorn N, Tuangsintanakul T, Rattanatanyong P, Tiwawech D, Mutirangura A. LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Clin Chim Acta. 2012;413(9):869-74.
30. Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, et al. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS ONE. 2011;6(2):e17014.
31. Zhu M-C, Xu Y-J, Zou X, Yan F. Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer. Int J Colorectal Dis. 2012;27(1):31-6.
32. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8(5):329-40. (Pubitemid 351596394)